STAT3 and neoplasm: A recent studies showed that Stat3 is frequently activated not only in diverse cancer cells by common oncogenic pathways, but also in tumor endothelial and myeloid cells, including Gr1+/CD11b+ (MDSCs) and tumor-associated macrophages, mediating immune suppression [34], [45].